Return to the catalog
MOTS-c
NewIn Stock20mg vial

MOTS-c

Mitochondrial peptide studied for energy use, blood-sugar control, and exercise response.

For Research Use Only

Sold strictly for laboratory research. Not for human or veterinary use, ingestion, or clinical/diagnostic application.

1–4 vialsR 800.00
5+ vials — save 31%R 550.00 each

The lower price is applied automatically once your cart holds 5 or more of this vial.

Bacteriostatic water included

99%+ Purity
Extensively Researched
1

About this peptide

MOTS-c is a 16-amino-acid peptide produced from genetic material inside mitochondria, the parts of cells that generate energy. Researchers study how it affects the way cells use sugar and fat, especially during metabolic stress and exercise. Much of the work focuses on AMPK, an important sensor that helps cells manage energy.

Why researchers reach for MOTS-c

AMPK activation

Engages the folate-methionine-AMPK axis in preclinical work.

Insulin sensitivity

Improved glucose disposal in rodent metabolic models.

Exercise mimetic

Referenced in mitochondrial biogenesis and endurance research.

Key features

  • ≥99% HPLC purity
  • 16-residue mitochondrial peptide
  • Mass-spec verified
  • Cold-chain dispatch

How it works

Metabolic sensor

Modulates folate cycle and AICAR accumulation.

AMPK signaling

Downstream activation of AMPK-driven catabolic programs.

Mitochondrial cross-talk

Communicates mitochondrial state to the nucleus.

Research dosage guidelines

Reference ranges only — reproduced from published preclinical literature. Not a recommendation for human use.

RangeReported doseNote
Typical reconstitution2 mL bacteriostatic waterYields 10 mg/mL (10 000 mcg/mL)
Reported research range5–10 mg/week (split)Reference only

Tracking this compound? Registered researchers can log active MOTS-c protocols in their private Research Log.

Timing in research protocols

Morning or pre-exercise timing is preclinical inference; human trials are only now under way.

  • A phase 2a trial (NCT07505745) is recruiting, using subcutaneous administration over a 12-week period; the regimen detail is not yet public.
  • Existing human data cover an analogue (CB4211) rather than native MOTS-c.
  • The exercise-mimetic rationale behind morning or pre-exercise dosing comes from rodent AMPK work, not human trials.
  • No published human time-of-day, meal or cycle-length evidence exists yet.

Drawn from published research protocols and pharmacology literature. Reference information for laboratory research only — not an instruction or guidance for use.

Technical specifications

Sequence
MRWQEMGYIFYPRKLR
Molecular weight
2174.6 g/mol
Purity
≥99% (HPLC)
Form
Lyophilized powder
Vial size
20 mg
Storage (lyophilised vial)
Cool, dry and protected from light
Storage (after reconstitution)
2–8°C

Published research

Peer-reviewed literature on MOTS-c. Links open in a new tab.

Research use notice

Sold for in vitro laboratory research only. Not for human or veterinary use, diagnosis, or therapy.

#mitochondrial#AMPK#longevity

Cart (0)

Your cart is empty